The Benefits And Risks Of Dpp 4-Inhibitors Vs. Sulfonylureas For Patients With Type 2 Diabetes
Sted with easy metabolic optimization following an `ambiguous intermediate' engineering concept. In other words, we propose a novel strategy that relies on liberation of rare sense codons from the genetic…